Gadolinium — DTPA in magnetic resonance imaging of the brain
Copyright policy )Gadolinium — DTPA in magnetic resonance imaging of the brain
This report concerns a clinical trial with Gd-DTPA as an intravenous contrast medium for MRI in patients with neurological disorders. 50 patients (30 female, 20 male) were examined without and with Gd-DTPA and the results of CT scanning and MR scanning without and with Gd-DTPA were compared. All patients tolerated the contrast medium very well. In the various patient groups, Gd-DTPA often added to the information. This was especially true in the tumor group, where better delineation of tumor, blood, and edema was obtained.
- University of Amsterdam Netherlands
Adult, Gadolinium DTPA, Male, Brain Diseases, Brain Neoplasms, Brain, Gadolinium, Middle Aged, Pentetic Acid, Magnetic Resonance Imaging, Organometallic Compounds, Humans, Female, Tomography, X-Ray Computed, Aged
Adult, Gadolinium DTPA, Male, Brain Diseases, Brain Neoplasms, Brain, Gadolinium, Middle Aged, Pentetic Acid, Magnetic Resonance Imaging, Organometallic Compounds, Humans, Female, Tomography, X-Ray Computed, Aged
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).5 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!